GW RESEARCH LIMITED Trademark Portfolio

Portfolio Overview

Top Classes

Class 005 (Pharmaceuticals), Class 041 (Education & Entertainment), Class 044 (Medical Services), Class 042 (Software & IT), Class 016 (Paper Goods), Class 036 (Financial Services)

Recently Registered Marks

• UNSPOKEN SYMPHONY — registered 2024-01-23
• UNSPOKEN SYMPHONY — registered 2024-01-23
• STRAIGHT FACTS ON CBD — registered 2024-01-16
• UNSPOKEN SYMPHONY — registered 2023-08-01
• ILLUMINATE STUDY — registered 2023-08-01

Recently Filed Applications

• UNSPOKEN SYMPHONY — filed 2023-05-22 (Registered)
• UNSPOKEN SYMPHONY — filed 2023-05-22 (Registered)
• UNSPOKEN SYMPHONY — filed 2022-06-24 (Registered)
• UNSPOKEN SYMPHONY — filed 2022-06-24 (Registered)
• STRAIGHT FACTS ON CBD — filed 2021-04-23 (Registered)

Top Marks

• UNSPOKEN SYMPHONY — Registered
• UNSPOKEN SYMPHONY — Registered
• STRAIGHT FACTS ON CBD — Registered
• UNSPOKEN SYMPHONY — Registered
• UNSPOKEN SYMPHONY — Registered
• ILLUMINATE STUDY — Registered
• STRAIGHT FACTS ON CBD — Registered
• EPIX — Registered
• IMPACT — Registered
• CANNABINOID CLINICAL — Registered
• ENGAGE BY GREENWICH BIOSCIENCES — Cancelled
• KYTEUVIA — Cancelled
• KATEULIA — Cancelled
• EPINUKIA — Cancelled
• KYNEUBIA — Cancelled
• ASCELTA — Cancelled
• EPIVARIN — Cancelled
• EPIVARINEX — Cancelled
• CEPAEDEX — Cancelled
• COMBIDIOL — Cancelled
• COMBIDIOLEX — Cancelled
• TETRANABINEX — Cancelled
• NABIDIOLEX — Cancelled
• CANNABIDEX — Cancelled
• NEONABIDEX — Cancelled
• NEODIOLEX — Cancelled
• NEODIOL — Cancelled
• UNSPOKEN SYMPHONY — Abandoned
• UNSPOKEN SYMPHONY — Abandoned
• MOTIVY — Abandoned
• MUVICITY — Abandoned
• ACSESLY — Abandoned
• AVRULEY — Abandoned
• LIBMUVO — Abandoned
• MOVIMI — Abandoned
• RIKLEMY — Abandoned
• STRAIGHT FACTS ON CBD — Abandoned
• CANNABIDEX — Abandoned
• CRI — Abandoned
• GREENWICH BIOSCIENCES — Abandoned

Related

• TTAB activity for GW RESEARCH LIMITED
• Search marks by GW RESEARCH LIMITED
• Free USPTO trademark search